Trademark: 88655362
Word
R2 REVLIMID/RITUXIMAB
Status Date
Tuesday, June 9, 2020
Registration Number
6073615
Registration Date
Tuesday, June 9, 2020
Filing Date
Tuesday, October 15, 2019
Published for Opposition
Tuesday, March 24, 2020
5 Pharmaceutical preparations for the treatment of certain cancers; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all the aforementioned goods being comprised in part of rituximab
44 Medical information and counseling in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical information and counseling in the field of lenalidomide and rituximab and safety issues pertaining to lenalidomide and rituximab, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; providing a web site featuring medical information; providing an internet website for medical professionals and medical patients featuring medical information; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmaceutical advice; providing medical information, consultancy and advisory services; all the aforementioned services relating to rituximab
The mark consists of the letter "R" appearing with the exponent "2" in blue next to the wording "REVLIMID/" with the letters appearing in black and the forward slash appearing in yellow, above the wording "RITUXIMAB" appearing in black.
The color(s) blue, black and yellow is/are claimed as a feature of the mark.
"RITUXIMAB"
Dec 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 9, 2022
Teas Change Of Correspondence Received
Dec 9, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 9, 2022
Teas Change Of Owner Address Received
Jun 9, 2020
Registered-Principal Register
Mar 24, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 24, 2020
Published For Opposition
Mar 4, 2020
Notification Of Notice Of Publication E-Mailed
Feb 17, 2020
Approved For Pub - Principal Register
Feb 17, 2020
Examiner's Amendment Entered
Feb 17, 2020
Notification Of Examiners Amendment E-Mailed
Feb 17, 2020
Examiners Amendment E-Mailed
Feb 17, 2020
Examiners Amendment -Written
Feb 13, 2020
Previous Allowance Count Withdrawn
Jan 28, 2020
Withdrawn From Pub - Og Review Query
Jan 13, 2020
Assigned To Lie
Jan 8, 2020
Approved For Pub - Principal Register
Jan 7, 2020
Teas/Email Correspondence Entered
Jan 7, 2020
Correspondence Received In Law Office
Jan 7, 2020
Teas Response To Office Action Received
Jan 6, 2020
Notification Of Non-Final Action E-Mailed
Jan 6, 2020
Non-Final Action E-Mailed
Jan 6, 2020
Non-Final Action Written
Dec 30, 2019
Assigned To Examiner
Oct 22, 2019
Notice Of Design Search Code E-Mailed
Oct 19, 2019
New Application Office Supplied Data Entered In Tram
Oct 18, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
